Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2.
Muhammad U. AnwaarFarjad AdnanAsma AbroRayyan A. KhanAsad U. RehmanMuhammad OsamaChristopher RainvilleSuresh KumarDavid E. SternerSaad JavedSyed B. JamalAhmadullah BaigMuhammad R. ShabbirWaseh AhsanTauseef R. ButtMuhammad Z. AssirPublished in: Comput. Biol. Medicine (2022)